Concepedia

Dilawar Khan

DK

Statistics

Publications

5

Citations

156

H-Index

5

Active since

2011

Affiliations

National University of Technology(Current)

Dilawar Khan is an author at National University of Technology specializing in oncology, cancer pharmacology, and medicine.

Publications per year

2011–2021

5

Publications

5

Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study

Eric S. Winer, Howard Safran, Bogusława Karaszewska et al. · International Journal of Hematology · 2017 · 63 citations

Medicine, Hematology, Oncology +13

5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia

Jessica Roos, Claudia Oancea, Maria Heinßmann et al. · Cancer Research · 2014 · 51 citations

Medicine, Oncology, Pharmacology +17

Analysis of homicidal deaths in district DI Khan: an autopsy study.

Muhammad Humayun, Dilawar Khan, Fasee-uz-Zaman et al. · PubMed · 2011 · 20 citations

Law, Toxicology, Crime +14

Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations

Dilawar Khan, Daniel Kirby, Simon Bryson et al. · Pharmaceutics · 2021 · 11 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

Mariam Fatima, Salik Javed Kakar, Fazal Adnan et al. · BMC Cancer · 2021 · 11 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 5